Nacuda, Baby Bou .
HRN: 21-99-20 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/08/2022
AMPICILLIN 250MG (VIAL)
10/08/2022
10/15/2022
IV
160mg
Q12
PSNB; PROM X 19hrs
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes